Phenobarbitone

  • Description and indication for use

    Phenobarbitone is a long-acting barbiturate with sedative hypnotic and anti-convulsant properties.  It is used in the management of seizures.

    Dose

    Loading dose:

    20 mg – 40 mg/kg.  ** (If ventilated, repeat doses of 10 – 15 mg/kg up to 100 mg/kg in 24 hours may be administered).

    Maintenance:

    3 – 5 mg/kg/day once daily or in 2 divided doses.  Adjust according to levels.  Commence 24 hrs after loading dose.

    Reconstitution/Dilution

    Ampoule = 200 mg in 1 mL or 20 mg in 0.5 mL.

    IV:

    * Dilute to 100 mg/mL with Sodium Chloride 0.9%.

    (Withdraw 1 mL of 200 mg/mL solution and add to 1 mL of water for injections in a 2 mL syringe = 200 mg/2 mL = 100 mg/mL).

    Discard excess volume to obtain required dose or withdraw dose using another syringe.

    IM:

    Use 200 mg/mL undiluted.

    Route and method of administration

    iv:

    Give at 1 mg/kg/minute or slower (maximum IV push rate in an emergency 2 mg/kg/minute).

    Loading dose over 30 minutes.

    Side effects

    Drowsiness.

    Respiratory depression, apnoea.

    Thrombophlebitis.

    Hypotension.

    Hepatitis, cholestasis.

    Note: Injection contains Propylene Glycol 90% and Benzyl Alcohol 10 mg/mL.

    Compatible Solutions

    Glucose 5% and 10%.

    Sodium Chloride 0.9%.

    Incompatibilities

    Phenobarbitone must not be mixed together with the following drugs: Most antibiotics, Morphine, Noradrenaline, Phenytoin Sodium.

    Avoid mixing with other drugs - flush before and after with Sodium Chloride 0.9%.

    Special precautions

    CAUTION in patients with severe hepatic or renal impairment.

    CAUTION in patients with hypotension or respiratory depression.

    Half-life of Phenobarbitone may be prolonged in patients with asphyxia.

    Greater than 20 mg/kg/dose in neonates may require mechanical ventilation.

    Drug interactions

    Phenobarbitone

    May alter the effect of many drugs as it stimulates liver microsomal enzyme production resulting in reduced serum levels.

    Drugs it may affect include Theophylline, Metronidazole and Dexamethasone.

    Phenytoin Levels may be increased when given concurrently with Phenytoin. Monitor serum levels of both drugs.
    Paracetamol Do not give high doses if giving Phenobarbitone.
    Chloramphenicol May have its effectiveness reduced and, in turn, reduce the effectiveness of Phenobarbitone.
    Rifampicin May reduce effectiveness of Phenobarbitone.

    Nursing responsibilities

    Cardiorespiratory monitor

    Apply pulse oxymeter +/- transcutaneous CO2 monitor.

    Check serum levels prn (therapeutic levels = 80 – 120 micromol/L).

    Observe IV site for signs of extravasation and phlebitis.

    Sampling time for levels immediately before the next dose.

Disclaimer:  This Drug information was designed for use by PIPER Neonatal. Whilst great care has been taken to check the information is accurate, it is possible that errors may have been missed. Furthermore, dosage schedules are continually being revised and new side effects recognised. For these reasons, the reader is strongly advised to consult the drug companies' printed information before administering any of the drugs recommended in this book.
Most drugs in this document are appropriate only for specialist use in hospitals.  A number of drugs should only be used in consultation with the appropriate Paediatric subspecialist. 

Note: The electronic version of this guideline is the version currently in use.  Any printed version cannot be assumed to be current. Printed copies of this document are valid for